Atossa Therapeutics, Inc. Gains 59.36%
Mon, Jan 25, 2021 at 05:30 PM
Atossa Therapeutics, Inc. (ATOS:NASDAQ) shot up at $2.98, representing a gain of 59.4%. On Fri 22 Jan 21, ATOS:NASDAQ touched a New 2-Week High of $1.87. The stock got featured on our News Catalysts scanner on Mon 25 Jan 21 at 09:40 AM in the 'MISCELLANEOUS' category. From Fri 08 Jan 21, the stock recorded 77.78% Up Days and 50.00% Green Days
The stock spiked on Mon 03 Aug 20 at $5.08 with a volume of 3M+.
About Atossa Therapeutics, Inc. (ATOS:NASDAQ)
Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
Top 10 Gainers:
- Express, Inc. (EXPR:NYSE), 131.84%
- Aemetis, Inc. (AMTX:NASDAQ), 100%
- Koss Corporation (KOSS:NASDAQ), 79.64%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 59.36%
- OEG (OEG:NASDAQ), 59%
- YGMZ (YGMZ:NASDAQ), 54.8%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 53.65%
- IZEA Worldwide, Inc. (IZEA:NASDAQ), 48.83%
- Ideal Power Inc. (IPWR:NASDAQ), 48.14%
- Accelerate Diagnostics, Inc. (AXDX:NASDAQ), 47.61%